nVerses Capital’s Prothena PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
nVerses Capital's PRTA Position: Q3 2026 in Review
nVerses Capital sold out of Prothena (PRTA) in Q3 2026, closing a stake of 13,246 shares — an estimated $130K sold.
nVerses Capital first reported a position in PRTA in Q2 2026 and held it in 1 quarter. The position peaked at $130K in Q2 2026. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- nVerses Capital reported no remaining Prothena position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 13,246 Prothena shares in Q3 2026, an estimated $130K.
- nVerses Capital first reported a position in Prothena in Q2 2026 and held it in 1 quarter.
- nVerses Capital's Prothena position peaked at $130K in Q2 2026.
- 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.